Design of the Prostate Cancer Prevention Trial (PCPT)
- 30 June 1995
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 16 (3) , 150-163
- https://doi.org/10.1016/0197-2456(94)00xxx-m
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994
- Statistical design and monitoring of the carotene and retinol efficacy trial (CARET)Controlled Clinical Trials, 1993
- A Decision Analysis of Alternative Treatment Strategies for Clinically Localized Prostate CancerPublished by American Medical Association (AMA) ,1993
- The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasiaThe Prostate, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black malesThe Lancet, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- The role of internal pilot studies in increasing the efficiency of clinical trialsStatistics in Medicine, 1990
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989
- Latent Prostatic Cancer in a Consecutive Autopsy SeriesScandinavian Journal of Urology and Nephrology, 1980